» Articles » PMID: 21678400

Resveratrol-induced Apoptosis is Enhanced in Low PH Environments Associated with Cancer

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2011 Jun 17
PMID 21678400
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Many critical factors such as hypoxia, nutrient deficiency, activation of glycolytic pathway/Warburg effect contribute to the observed low pH in tumors compared to normal tissue. Studies suggest that such tumor specific acidic environment can be exploited for the development of therapeutic strategies against cancer. Independent observations show reduction in pH of mammalian cells undergoing internucleosomal DNA fragmentation and apoptosis. As such, our group has extensively demonstrated that anticancer mechanisms of different plant polyphenols involve mobilization of endogenous copper and consequent internucleosomal DNA breakage. Copper is redox active metal, an essential component of chromatin and is sensitive to subtle pH changes in its microenvironment. Here we explored whether, acidic pH promotes growth inhibition, apoptosis, and DNA damaging capacity of chemopreventive agent resveratrol. Our results reveal that growth inhibition and internucleosomal DNA fragmentation induced apoptosis in Capan-2 and Panc-28 pancreatic cancer cell lines (and not in normal HPDE cells) by resveratrol is enhanced at lower pH. Using comet assay, we further demonstrate that DNA breakage by resveratrol is enhanced with acidification. Membrane permeable copper specific chelator neocuproine (and not iron chelator orthophenanthroline) abrogated growth inhibition and apoptosis by resveratrol. Western blot results show enhanced activation of DNA laddering marker H2.aX by resveratrol at acidic pH that was reversed by neocuproine and not by orthophenanthroline. Our findings provide irrevocable proof that low pH environment can be turned into tumor weakness and assist in eradication of cancer cells by resveratrol.

Citing Articles

Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action.

Talib W, Baban M, Bulbul M, Al-Zaidaneen E, Allan A, Al-Rousan E Int J Mol Sci. 2024; 25(17).

PMID: 39273552 PMC: 11394730. DOI: 10.3390/ijms25179593.


A comprehensive review on phytochemicals in the treatment and prevention of pancreatic cancer: Focusing on their mechanism of action.

Arnab M, Islam M, Saydur Rahman M Health Sci Rep. 2024; 7(5):e2085.

PMID: 38690008 PMC: 11056788. DOI: 10.1002/hsr2.2085.


Radioprotective Potency of Nanoceria.

Alvandi M, Shaghaghi Z, Farzipour S, Marzhoseyni Z Curr Radiopharm. 2023; 17(2):138-147.

PMID: 37990425 DOI: 10.2174/0118744710267281231104170435.


Resveratrol Inhibits Activation of Microglia after Stroke through Triggering Translocation of Smo to Primary Cilia.

Liao H, Huang J, Liu J, Chen Y, Zhu H, Li X J Pers Med. 2023; 13(2).

PMID: 36836502 PMC: 9961736. DOI: 10.3390/jpm13020268.


Understanding the Prooxidant Action of Plant Polyphenols in the Cellular Microenvironment of Malignant Cells: Role of Copper and Therapeutic Implications.

Farhan M, Rizvi A Front Pharmacol. 2022; 13:929853.

PMID: 35795551 PMC: 9251333. DOI: 10.3389/fphar.2022.929853.


References
1.
Azmi A, Bhat S, Hadi S . Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett. 2005; 579(14):3131-5. DOI: 10.1016/j.febslet.2005.04.077. View

2.
Ahsan H, Parveen N, Khan N, Hadi S . Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact. 1999; 121(2):161-75. DOI: 10.1016/s0009-2797(99)00096-4. View

3.
Clement M, Hirpara J, Chawdhury S, Pervaiz S . Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 1998; 92(3):996-1002. View

4.
Barry M, Eastman A . Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. Biochem Biophys Res Commun. 1992; 186(2):782-9. DOI: 10.1016/0006-291x(92)90814-2. View

5.
Gerweck L, Seetharaman K . Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 1996; 56(6):1194-8. View